You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Panhandle Oil & Gas (PHX) delivered earnings and revenue surprises of 950.00% and 55.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
ProQR (PRQR) doses the first patient in the phase I/II Aurora study on QR-1123, which is being evaluated for treating patients with autosomal dominant retinitis pigmentosa.
Activision Blizzard (ATVI) is benefiting from franchise strength. The introduction of Call of Duty: Modern Warfare Battle Pass is expected to boost revenue growth.
BioCryst (BCRX) files a new drug application to the FDA for once-daily berotralstat (BCX7353), which is being developed for the prevention of hereditary angioedema attacks.
Failed drilling of the Resolution well and disappointing results from its partners' Ghana fields induce Kosmos' (KOS) share price fall, thereby hurting investor confidence.
Humana (HUM) collaborates with Monogram Health and Somatus to provide its Humana Medicare Advantage and Commercial members, who are renal patients, with better healthcare in select geographies.
Children's Place (PLCE) earnings beat estimates in third-quarter fiscal 2019, while sales missed the same. Moreover, the company trimmed view for fiscal 2019 hurting investors' sentiment.
IHS Markit's (INFO) business model ensures solid recurring revenue generation capacity, allowing the company to deliver stable revenues and predictable cash flows.
lululemon (LULU) delivers solid third-quarter fiscal 2019 results on positive customer response to merchandise assortments as well as continued investments to drive business growth.
Best Buy's (BBY) Building the New Blue: Chapter Two plan and buyouts are likely to keep its momentum alive in the near future. Also, a raised view for fiscal 2020 bodes well.
Starbucks (SBUX) continues to benefit from robust performance by the Americas and China-Asia-Pacific segments, store openings, enhanced customer experience and, digitalization.
Ciena's (CIEN) fiscal fourth-quarter results reflect market share gains on the back of technology leadership and diversified customer base in high-growth markets.
American Eagle (AEO) posts in-line earnings in third-quarter fiscal 2019. However, soft earnings view for the fiscal fourth quarter is hurting investors' sentiments.
Factors like the ongoing trade uncertainty and sluggish industrial production are likely to have hampered FedEx (FDX) Express performance in second-quarter fiscal 2020.
Zacks.com Most Recent Articles
Panhandle Oil & Gas (PHX) Tops Q4 Earnings and Revenue Estimates
Tale of the Tape
by Zacks Equity Research
Panhandle Oil & Gas (PHX) delivered earnings and revenue surprises of 950.00% and 55.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
PHX
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Tech Earnings Beat After Hours: ORCL, ADBE, AVGO
Analyst Blog
by Mark Vickery
A burst of earnings report activity has hit the tape after Thursday's closing bell, with positive results from Oracle, Adobe and Broadcom.
ADBE ORCL AVGO
tech-stocks
Home Depot (HD) Stock Takes a Hit on Soft Fiscal 2020 View
Analyst Blog
by Rajani Lohia
Home Depot (HD) provides an update on One Home Depot Plan and outlines view for fiscal 2020.
BLDR HD WMT TGT
retail
ProQR (PRQR) Begins Dosing in Phase I/II Eye Disorder Study
Analyst Blog
by Zacks Equity Research
ProQR (PRQR) doses the first patient in the phase I/II Aurora study on QR-1123, which is being evaluated for treating patients with autosomal dominant retinitis pigmentosa.
PRQR ANIK IONS GH
biotechs
Activision Rides on Franchise Strength & New COD Release
Analyst Blog
by Aniruddha Ganguly
Activision Blizzard (ATVI) is benefiting from franchise strength. The introduction of Call of Duty: Modern Warfare Battle Pass is expected to boost revenue growth.
ZNGA ATVI TTWO EA
tech-stocks
BioCryst Submits NDA for Hereditary Angioedema Candidate
Analyst Blog
by Zacks Equity Research
BioCryst (BCRX) files a new drug application to the FDA for once-daily berotralstat (BCX7353), which is being developed for the prevention of hereditary angioedema attacks.
INVA ANIK BCRX GH
medical
Garmin, Movado and Tesla highlighted as Zacks Bull and Bear of the Day
Press Releases
by Zacks Equity Research
Garmin, Movado and Tesla highlighted as Zacks Bull and Bear of the Day
TSLA GRMN MOV
industrial-products
Cigna Considers Divesting Its Non-Health Insurance Business
Analyst Blog
by Zacks Equity Research
Speculations ran rife that Cigna (CI) is on the lookout of a bidder for its non-health insurance arm to streamline in-house operations.
LNC SLF CI MET
medical
Kosmos (KOS) Dives Due to Partners' Ghana Production Issues
Analyst Blog
by Zacks Equity Research
Failed drilling of the Resolution well and disappointing results from its partners' Ghana fields induce Kosmos' (KOS) share price fall, thereby hurting investor confidence.
KOS TUWOY BP HES
oil-energy
Humana's (HUM) Alliances to Offer Relief to Members With CKD
Analyst Blog
by Zacks Equity Research
Humana (HUM) collaborates with Monogram Health and Somatus to provide its Humana Medicare Advantage and Commercial members, who are renal patients, with better healthcare in select geographies.
SEM WCG HUM GEN
medical
Intersect ENT (XENT) Grows on Innovation Despite Cost Woes
Analyst Blog
by Zacks Equity Research
The latest offering in Intersect ENT's (XENT) SINUVA portfolio is specific J code - J7401.
XENT NUVA RMD HAE
medical
Walgreens Extends Deal to Form GPO With Retail Giant Kroger
Analyst Blog
by Zacks Equity Research
Per Walgreens (WBA), its alliance with Kroger will lead to supply chain efficiencies, capitalizing on their joint resources.
RMD HAE NUVA WBA
medical
Children's Place (PLCE) Beats on Q3 Earnings, View Soft
Analyst Blog
by Zacks Equity Research
Children's Place (PLCE) earnings beat estimates in third-quarter fiscal 2019, while sales missed the same. Moreover, the company trimmed view for fiscal 2019 hurting investors' sentiment.
ZUMZ TLYS PLCE BOOT
earnings retail
MoneyGram Extends Tie-Up With CVS for Seamless Transactions
Analyst Blog
by Zacks Equity Research
MoneyGram (MGI) expands its relationship with retail pharmacy chain CVS to facilitate fast and smooth money transfer options to customers.
ONDK MGI PRAA EQH
finance
Here's Why Investors Should Hold on to IHS Markit Stock
Analyst Blog
by Zacks Equity Research
IHS Markit's (INFO) business model ensures solid recurring revenue generation capacity, allowing the company to deliver stable revenues and predictable cash flows.
CATM INFO GPN FISV
business-services
lululemon (LULU) Beats on Q3 Earnings & Sales, Stock Down
Analyst Blog
by Zacks Equity Research
lululemon (LULU) delivers solid third-quarter fiscal 2019 results on positive customer response to merchandise assortments as well as continued investments to drive business growth.
LULU DECK CROX TLRD
consumer-discretionary earnings
Dine Brands (DIN) Plans to Launch Fast Casual Concept in 2020
Analyst Blog
by Zacks Equity Research
Dine Brands (DIN) to launch Flip'd by IHOP--- a new fast casual concept--- in the United States by spring 2020.
DIN CMG DNKN CHUY
retail
Best Buy Hits New 52-Week High: Will the Uptrend Continue?
Analyst Blog
by Zacks Equity Research
Best Buy's (BBY) Building the New Blue: Chapter Two plan and buyouts are likely to keep its momentum alive in the near future. Also, a raised view for fiscal 2020 bodes well.
BBY TGT DKS BOOT
retail
Gilead Teams Up With Kiniksa, Submits BLA for CAR T Therapy
Analyst Blog
by Zacks Equity Research
Gilead (GILD) collaborates with Kiniksa for a combination study and submits BLA for CAR T therapy candidate.
NVS GSK GILD KNSA
biotechs
Can Starbucks (SBUX) Replicate '19 Performance in 2020?
Analyst Blog
by Zacks Equity Research
Starbucks (SBUX) continues to benefit from robust performance by the Americas and China-Asia-Pacific segments, store openings, enhanced customer experience and, digitalization.
EAT SBUX LOCO CMG
restaurants
Broadcom Develops Automation.ai to Support AIOps Growth
Analyst Blog
by Zacks Equity Research
Broadcom's (AVGO) new Automation.ai is likely to enable improved and faster decision making for client companies.
IBM SNPS AVGO KEYS
semiconductor
Ciena (CIEN) Q4 Earnings Miss Estimates, Revenues Rise Y/Y
Analyst Blog
by Zacks Equity Research
Ciena's (CIEN) fiscal fourth-quarter results reflect market share gains on the back of technology leadership and diversified customer base in high-growth markets.
QCOM PCTI CIEN UI
earnings tech-stocks
Netflix's Streaming Dominance Challenged by Disney & Apple
Analyst Blog
by Aniruddha Ganguly
Netflix (NFLX) is facing significant challenges from Apple and Disney in the streaming space.
DIS NFLX AMZN AAPL
consumer-discretionary internet-content tech-stocks
Company News for Dec 12, 2019
Corporate Summary
by Zacks Equity Research
Companies in the news are: PLAB, OLLI, LOGM, GME
OLLI LOGM GME PLAB
consumer-discretionary tech-stocks
American Eagle (AEO) Slumps 7% Despite In-Line Earnings in Q3
Analyst Blog
by Zacks Equity Research
American Eagle (AEO) posts in-line earnings in third-quarter fiscal 2019. However, soft earnings view for the fiscal fourth quarter is hurting investors' sentiments.
ZUMZ AEO TLYS BOOT
earnings retail
Canadian Solar Receives Approval for $150M Share Repurchase
Analyst Blog
by Zacks Equity Research
Canadian Solar (CSIQ) currently has a 4-GW pipeline of late-stage, utility-scale solar power projects, with another 415 MWp lined up for construction.
CSIQ JKS SEDG SOL
oil-energy
Is Telefonica (TEF) a Profitable Stock for Value Investors?
Analyst Blog
by Zacks Equity Research
Let's see if Telefonica (TEF) stock is a good choice for value-oriented investors right now from multiple angles.
TEF
undervalued-stocks utilities
Will Express Unit Weakness Mar FedEx's (FDX) Earnings in Q2?
Analyst Blog
by Zacks Equity Research
Factors like the ongoing trade uncertainty and sluggish industrial production are likely to have hampered FedEx (FDX) Express performance in second-quarter fiscal 2020.
ALGT AMZN UPS FDX
transportation
Why Do Options on the Same Stock Trade at Different Implied Vols?
Know Your Options
by David Borun
The normal distribution assumption in option pricing models doesn't accurately reflect real life
options
Bear of the Day: Movado (MOV)
Bear of the Day
by Madeleine Johnson
This traditional watchmaker is stuck in a sales rut.
SIG MOV
retail